Bioverativ
http://dbpedia.org/resource/Bioverativ an entity of type: Thing
Bioverativ Inc. is an American multinational biotechnology company that specializes in the discovery, development, and delivery of therapies for the treatment of haemophilia. Bioverativ competes with Baxalta (acquired by Shire Plc in 2016), Pfizer and Novo Nordisk. The company traded on the NASDAQ exchange under the ticker symbol BIVV until Sanofi completed its acquisition on March 8, 2018.
rdf:langString
rdf:langString
Bioverativ
rdf:langString
Bioverativ Inc.
rdf:langString
Bioverativ Inc.
xsd:integer
51795199
xsd:integer
1107752903
xsd:integer
2016
rdf:langString
rdf:langString
rdf:langString
John G. Cox
xsd:integer
400
rdf:langString
Alprolix, Eloctate
rdf:langString
Bioverativ Inc. is an American multinational biotechnology company that specializes in the discovery, development, and delivery of therapies for the treatment of haemophilia. Bioverativ competes with Baxalta (acquired by Shire Plc in 2016), Pfizer and Novo Nordisk. The company traded on the NASDAQ exchange under the ticker symbol BIVV until Sanofi completed its acquisition on March 8, 2018.
xsd:nonNegativeInteger
6916
xsd:gYear
2016
xsd:nonNegativeInteger
400